Tuberculosis is a significant problem in children on biologics for rheumatic illnesses: Results from a survey conducted among practicing rheumatologists in India
Background: India is endemic for tuberculosis (TB) and the use of immunosuppressants is likely to accentuate the problem. Whilst steroids and conventional disease modifying anti-rheumatic drugs (DMARDs) are believed to increase the risk for tuberculosis, certain biologics such as B cell depleting ag...
Main Authors: | G Chengappa Kavadichanda, Latika Gupta, Suma Balan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=2;spage=130;epage=133;aulast=Kavadichanda |
Similar Items
-
Pediatric rheumatology: An under-recognized subspecialty in India
by: Akhila Kavirayani, et al.
Published: (2017-01-01) -
Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders
by: Jacob N. Ablin, et al.
Published: (2016-04-01) -
Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases
by: Joel Reis, et al.
Published: (2016-01-01) -
Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists
by: Anna Nicek, et al.
Published: (2020-07-01) -
Self-management skills in adolescents with chronic rheumatic disease: A cross-sectional survey
by: Lawson Erica F, et al.
Published: (2011-12-01)